Naltrexone Accord Healthcare (Naltrexone Hydrochloride)

Naltrexone works as a competitive antagonist at mu, kappa and delta opioid receptors. It binds to these receptors without activating them, thereby blocking the effects of both endogenous opioids and external opioid drugs, which diminishes the rewarding sensations and reduces cravings associated with alcohol and opioid use.

The appropriate dose of Naltrexone Accord Healthcare is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other clinical factors. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

The safety of Naltrexone during pregnancy and lactation has not been definitively established, and the pregnancy category is listed as unknown. Healthcare providers should weigh the potential benefits against possible risks and consider alternative treatments when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Naltrexone differs from opioid agonist therapies such as methadone or buprenorphine because it blocks opioid receptors rather than activating them. This antagonistic action eliminates opioid euphoria and reduces cravings, making it suitable for patients who prefer a non‑opioid approach, though it requires a period of opioid‑free status before initiation.

Naltrexone Accord Healthcare should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

The medication is supplied as oral tablets intended for swallowing with water. It is taken by mouth as directed by the prescribing clinician, typically on a regular schedule, and should be used consistently to achieve the desired therapeutic effect.

Serious risks include hepatotoxicity, severe depression or suicidal thoughts, allergic reactions such as rash or angioedema, and the potential for precipitated opioid withdrawal if administered to individuals with recent opioid use. Patients should be monitored closely for these events and seek immediate medical attention if they occur.

Naltrexone is contraindicated in individuals with a known hypersensitivity to the drug, those currently undergoing opioid therapy or in acute opioid withdrawal, and patients with severe hepatic impairment. It should also be used with caution in pregnant or breastfeeding women, and under medical supervision in all other cases.